104 related articles for article (PubMed ID: 22905419)
1. [Heterosubtypic immunity to influenza A viruses: epidemiological data, involvement of different immunological factors, vaccination].
Naĭkhin AN
Vopr Virusol; 2012; 57(3):4-9. PubMed ID: 22905419
[TBL] [Abstract][Full Text] [Related]
2. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
[TBL] [Abstract][Full Text] [Related]
3. Universal influenza vaccines: a realistic option?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S120-S124. PubMed ID: 27130671
[TBL] [Abstract][Full Text] [Related]
4. Pediatric influenza vaccination: understanding the T-cell response.
Bodewes R; Fraaij PL; Osterhaus AD; Rimmelzwaan GF
Expert Rev Vaccines; 2012 Aug; 11(8):963-71. PubMed ID: 23002977
[TBL] [Abstract][Full Text] [Related]
5. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
Crank MC; Mascola JR; Graham BS
J Infect Dis; 2019 Apr; 219(Suppl_1):S107-S109. PubMed ID: 30715413
[No Abstract] [Full Text] [Related]
6. Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.
Laidlaw BJ; Decman V; Ali MA; Abt MC; Wolf AI; Monticelli LA; Mozdzanowska K; Angelosanto JM; Artis D; Erikson J; Wherry EJ
PLoS Pathog; 2013 Mar; 9(3):e1003207. PubMed ID: 23516357
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and predictors for homo- and heterosubtypic antibodies against influenza a virus.
Kohler I; Scherrer AU; Zagordi O; Bianchi M; Wyrzucki A; Steck M; Ledergerber B; Günthard HF; Hangartner L
Clin Infect Dis; 2014 Nov; 59(10):1386-93. PubMed ID: 25139962
[TBL] [Abstract][Full Text] [Related]
8. Immunity to seasonal and pandemic influenza A viruses.
Valkenburg SA; Rutigliano JA; Ellebedy AH; Doherty PC; Thomas PG; Kedzierska K
Microbes Infect; 2011 May; 13(5):489-501. PubMed ID: 21295153
[TBL] [Abstract][Full Text] [Related]
9. [Immunity against influenza virus infection].
Takada A
Nihon Rinsho; 2010 Sep; 68(9):1625-30. PubMed ID: 20845738
[TBL] [Abstract][Full Text] [Related]
10. Pandemic preparedness: toward a universal influenza vaccine.
Roose K; Fiers W; Saelens X
Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.
Bodewes R; Kreijtz JH; Hillaire ML; Geelhoed-Mieras MM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Gen Virol; 2010 Jul; 91(Pt 7):1743-53. PubMed ID: 20335492
[TBL] [Abstract][Full Text] [Related]
12. Emerging influenza viruses and the prospect of a universal influenza virus vaccine.
Krammer F
Biotechnol J; 2015 May; 10(5):690-701. PubMed ID: 25728134
[TBL] [Abstract][Full Text] [Related]
13. Universal influenza vaccines, science fiction or soon reality?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
[TBL] [Abstract][Full Text] [Related]
14. Development of live attenuated influenza vaccines against pandemic influenza strains.
Coelingh KL; Luke CJ; Jin H; Talaat KR
Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
[TBL] [Abstract][Full Text] [Related]
15. Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
Brown LE; Kelso A
Immunol Cell Biol; 2009; 87(4):300-8. PubMed ID: 19308073
[TBL] [Abstract][Full Text] [Related]
16. Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.
Bolton KJ; McCaw JM; Brown L; Jackson D; Kedzierska K; McVernon J
PLoS One; 2015; 10(3):e0120138. PubMed ID: 25811654
[TBL] [Abstract][Full Text] [Related]
17. Keeping the memory of influenza viruses.
Combadière B; Sibéril S; Duffy D
Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
[TBL] [Abstract][Full Text] [Related]
18. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
Altenburg AF; Rimmelzwaan GF; de Vries RD
Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
[TBL] [Abstract][Full Text] [Related]
19. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
Isakova-Sivak I; Rudenko L
Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
[TBL] [Abstract][Full Text] [Related]
20. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
Rudenko L; Isakova-Sivak I
Expert Rev Vaccines; 2015 Mar; 14(3):395-412. PubMed ID: 25555687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
